POSTER SESSION 1 & WELCOME RECEPTION

Sunday June 12, 2016: 18:00-20:00
Exhibition Space (30 Euston Square)

PS1

PS1-1

COST-EFFECTIVENESS OF RISK-BASED STRATIFIED BREAST CANCER SCREENING
Ian Jacob, BA (Hons), MA, MSc1, Gareth Evans, MD FCRP2 and Katherine Payne, BPharm, MSc, PhD1, (1)The University of Manchester, Manchester, United Kingdom, (2)Genomic Medicine, The University of Manchester, Manchester, United Kingdom
PS1-2

DECISION RULES FOR VALUE-BASED REIMBURSEMENT: MOVING ON FROM NET HEALTH BENEFIT
Mike Paulden, MA., MSc., University of Alberta, Edmonton, AB, Canada, Christopher McCabe, PhD, Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada and James O'Mahony, Trinity College Dublin, Dublin, Ireland
PS1-3

THE COST-EFFECTIVENESS OF POINT-OF-CARE TROPONIN TESTING TO DIAGNOSE ACUTE CORONARY SYNDROME IN PRIMARY CARE
Michelle M.A. Kip, MSc., Hendrik Koffijberg, PhD, Marco J. Moesker, MSc., Maarten J. IJzerman, PhD and Ron Kusters, PhD, University of Twente, Enschede, Netherlands
PS1-4

ESTIMATING THE CLINICAL IMPACT AND COSTS OF IMPLEMENTING A POINT OF CARE TEST FOR INFLUENZA A/B AND RESPIRATORY SYNCYTIAL VIRUS ON AN ACUTE PAEDIATRIC HOSPITAL INPATIENT WARD
Elisabeth Adams1, Andres Vecino Ortiz1, Rebecca Glover1, Sam Douthwaite2, Simon Goldenberg2 and Catherine Mak1, (1)Aquarius Population Health, London, United Kingdom, (2)Guy's and St Thomas' NHS Trust, London, United Kingdom
PS1-5

DO SURGERY JOURNALS REPORT RISK REDUCTION INFORMATION IN A WAY THAT COULD PROMOTE BIAS?
Dafina Petrova, MSc, Mind, Brain, and Behavior Research Center; University of Granada, Granada, Spain, Rocio Garcia-Retamero, PhD, University of Granada, Granada, Spain, Edward Cokely, PhD, National Institute for Risk & Resilience, and Department of Psychology, University of Oklahoma, USA, Norman, OK and Alexander Joeris, MD, AO Clinical Investigation and Documentation, Duebendorf, Switzerland
PS1-6

DO VISUAL AIDS IMPROVE DIAGNOSTIC INFERENCE?
Rocio Garcia-Retamero, PhD, University of Granada, Granada, Spain, Edward Cokely, PhD, National Institute for Risk & Resilience, and Department of Psychology, University of Oklahoma, USA, Norman, OK, Dafina Petrova, MSc, Mind, Brain, and Behavior Research Center; University of Granada, Granada, Spain and Ulrich Hoffrage, PhD, Faculty of Business and Economics, University of Lausanne, Lausanne, Switzerland
PS1-7

THE EFFECT OF EMPATHY ON RISK PERCEPTION FOR HEALTH VIGNETTES
Piers Fleming, Becky Renshaw-Fox, Becky Leggate, Jess Hall and Yasmine Haggar, University of East Anglia, Norwich, United Kingdom
PS1-8

TOLERANCE FOR AMBIGUITY AND STRESS: A STUDY AMONG ITALIAN PRACTICING PHYSICIANS
Paola Iannello, Alessandro Antonietti, Anna Mottini and Simone Tirelli, Catholic University of the Sacred Heart, Milan, Italy
PS1-9

SHARED DECISION MAKING IN ANTENATAL OBSTETRICS
Francesca Ker-Reid, School of Acute Care Common Stem, Severn Deanery, Bristol, United Kingdom, Matthew Ridd, Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom, Harini Narayan, Great Western Hospital, Swindon, United Kingdom and Alan Montgomery, Nottingham University, Nottingham, United Kingdom
PS1-10

THE BENEFIT-HARM BALANCE OF PROSTATE CANCER SCREENING IN MEN WITH AVERAGE AND ELEVATED FAMILIAL RISK – PREDICTIONS OF THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL
Nikolai Mühlberger, Assist.-Prof., DVM, MPH1, Kristijan Boskovic, MD2, Murray D. Krahn, MD, MSc3, Karen E Bremner, BSc4, Willi Oberaigner, Associate Prof., Dr.5, Helmut Klocker, A. Univ.Prof. Dr.6, Wolfgang Horninger, Univ.-Prof. Dr.6, Gaby Sroczynski, MPH, Dr.PH7 and Uwe Siebert, MD, MPH, MSc, ScD8, (1)Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology; Division of HTA and Bioinformatics, ONCOTYROL - Center for Personalized Cancer Medicine, Hall i.T./Innsbruck, Austria, (2)Department of Public Health, Health Services Research and Health Technology Assessment UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, (3)University of Toronto and University Health Network, Toronto General Research Institute, Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, (4)Toronto General Research Institute, Toronto General Hospital, Toronto, ON, Canada, (5)Cancer Registry of Tyrol, Tirol Kliniken GmbH, Innsbruck, Austria, (6)Department of Urology, Medical University of Innsbruck, Innsbruck, Austria, (7)UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and HTA, Department of Public Health, Health Services Research and HTA/ ONCOTYROL - Area 4, HTA and Bioinformatics, Hall i.T./Innsbruck, Austria, (8)UMIT, Hall in Tirol (Austria) / Boston (USA), Austria
PS1-11

INCREASING HIGH-VALUE VENOUS THROMBOEMBOLISM PROPHYLAXIS: A WIN-WIN SITUATION
Claire Jansson-Knodell, MD1, Melissa Myers, MD1, Sara Bonnes, MD2 and John Ratelle, MD2, (1)Mayo School of Graduate Medical Education, Rochester, MN, (2)Mayo Clinic, Rochester, MN
PS1-12

META-ANALYSIS AND INDIRECT TREATMENT COMPARISON OF SAFETY PROFILES OF BORTEZOMIB- AND THALIDOMIDE-BASED REGIMENS FOR THE FIRST LINE TREATMENT OF ELDERLY TRANSPLANT-INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA
Milica Jevdjevic, DMD1, Durda Vukicevic, MD2, Monika Buchberger, MSc2, Marjan Arvandi, MS1, Werner Hackl, DI Dr.3, Wolfgang Willenbacher, MD4, Guenther Gastl, MD5, Uwe Siebert, MD, MPH, MSc, ScD6 and Ursula Rochau, MD, MSc7, (1)Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i. T., Austria, (2)UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, Hall i.T., Austria, (3)Institute of Biomedical Informatics, Department of Biomedical Informatics and Mechatronics, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, Hall i.T., Austria, (4)Area 4 Health Technology Assessment and Bioinformatics, ONCOTYROL - Center for Personalized Cancer Medicine; Internal Medicine V, Hematology and Oncology, Medical University, Innsbruck, Austria, (5)Internal Medicine V, Hematology and Oncology, Medical University, Innsbruck, Austria, (6)Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, (7)UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and HTA, Department of Public Health and HTA/ ONCOTYROL - Center for Personalized Cancer Medicine, Area 4 HTA and Bioinformatics, Hall in Tyrol/ Innsbruck, Austria
PS1-13

AN OVERVIEW OF DIFFERENT MAPPING TECHNIQUES TO DERIVE HEALTH STATE UTILITY VALUES IN MULTIPLE MYELOMA FOR DECISION-ANALYTIC MODELING
Vjollca Qerimi, MPharm1, Beate Jahn, PhD2, Durda Vukicevic, MD2, Milica Jevdjevic, DMD3, Andrea Manca, PhD, MSc4, Bernhard Holzner, PhD5, Georg Kemmler, PhD5, Uwe Siebert, MD, MPH, MSc, ScD6 and Ursula Rochau, MD, MSc3, (1)Institute of Public Health, Medical Decision Making and HTA, Department of Public Health, Health Services Research and HTA, UMIT - University for Health Sciences, Medical Informatics and Technology / Faculty of Pharmacy, University of Skopje, Macedonia, Hall in Tyrol, Austria, (2)UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, Hall in Tyrol, Austria, (3)Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i. T., Austria, (4)The University of York, Centre for Health Economics, United Kingdom/ Department of Population Health, Luxembourg Institute of Health, Luxemburg, York, United Kingdom, (5)Medical University of Innsbruck, Department of Psychiatry and Psychotherapy, Innsbruck, Austria, (6)Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria
PS1-14

THE IMPACT OF THE ALCOHOL ACT ON ALCOHOL-RELATED HEALTH HARMS IN SCOTLAND
Jim Lewsey, PhD1, Mark Robinson2, Janet Bouttell1, Daniel Mackay1, Gerard McCartney2 and Clare Beeston2, (1)Institute of Health & Wellbeing, University of Glasgow, Glasgow, United Kingdom, (2)NHS Health Scotland, Glasgow, United Kingdom
PS1-15

ANALYSIS OF EYE GAZE PATTERNS AND DECISION-MAKING STRATEGIES DURING A DISCRETE CHOICE EXPERIMENT
Sian Martin1, Kielan Yarrow1, Kate Mandeville2, Stian Reimers1, Mylene Lagarde2 and Benjamin Cooper1, (1)City University London, London, United Kingdom, (2)London School of Hygiene and Tropical Medicine, London, United Kingdom
PS1-16

STRUCTURING BENEFIT-RISK MODELS IN PRESENCE OF NUMEROUS ADVERSE EVENTS: A CASE STUDY OF MULTIPLE SCLEROSIS
Sumitra Sri Bhashyam, PhD1, Heather Gelhorn, PhD2, Katharine Gries, PhD2, Kevin Marsh, PhD1, Jiat Ling Poon, PhD2, Anne Rentz, MSPH2 and Tommi Tervonen, PhD3, (1)Evidera, London, United Kingdom, (2)Evidera, Bethesda, WA, (3)Health Economics Center of Excellence, Evidera Ltd, London, United Kingdom
PS1-17

EXPLICIT – DEVELOPING A PLATFORM FOR ELICITING EXPERT OPINION FOR MODEL-BASED ECONOMIC EVALUATIONS
Bogdan Grigore, Jaime Peters, Christopher Hyde and Ken Stein, Institute for Health Research, University of Exeter Medical School, Exeter, United Kingdom
PS1-18

ASSESSING THE EXPECTED VALUE OF RESEARCH STUDIES IN REDUCING UNCERTAINTY AND IMPROVING IMPLEMENTATION DYNAMICS
Sabine Grimm, MSc BA, University of Sheffield, Sheffield, United Kingdom
PS1-19

A MULTI CRITERIA DECISION ANALYSIS-BASED APPROACH TO HEALTH TECHNOLOGY ASSESSMENT
Shane O Meachair, Msc, Trinity College Dublin, Dublin, Ireland and Cathal Walsh, PhD, University of Limerick, Limerick, Ireland
PS1-20

DECISION MAKING AND VALUE OF INFORMATION ANALYSIS IN A REAL-WORLD MULTI-CRITERIA CONTEXT
Hendrik Koffijberg, PhD, University of Twente, Enschede, Netherlands and Mart Janssen, PhD, University Medical Center Utrecht, Utrecht, Netherlands
PS1-21

TREATMENT STRATEGIES FOR MULTIPLE MYELOMA IN ELDERLY PATIENTS: A NETWORK META-ANALYSIS
Monika Buchberger, MSc1, Ursula Rochau, MD, MSc2, Durda Vukicevic, MD1, Wolfgang Willenbacher, MD3, Anna Chaimani, PhD, MSc4, Orestis Efthimiou, PhD4 and Uwe Siebert, MD, MPH, MSc, ScD5, (1)UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, Hall i.T., Austria, (2)UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and HTA, Department of Public Health and HTA/ ONCOTYROL - Center for Personalized Cancer Medicine, Area 4 HTA and Bioinformatics, Hall in Tyrol/ Innsbruck, Austria, (3)Internal Medicine V, Hematology and Oncology, Medical University, Innsbruck, Austria, (4)University of Ioannina, Department of Hygiene and Epidemiology, Ioannina, Greece, (5)UMIT, Hall in Tirol (Austria) / Boston (USA), Austria
See more of: 16th Biennial European Conference
<< Previous Session | Next Session >>